Distinct myoprotective roles of cardiac sarcolemmal and mitochondrial KATP channels during metabolic inhibition and recovery

FASEB J. 2001 Dec;15(14):2586-94. doi: 10.1096/fj.01-0188com.

Abstract

The protective roles of sarcolemmal (sarc) and mitochondrial (mito) KATP channels are unclear despite their apparent importance to ischemic preconditioning. We examined these roles by monitoring intracellular calcium ([Ca]int), using fura-2 and fluo-3, in enzymatically isolated rat right ventricular myocytes. Myocyte mortality, estimated using a trypan blue assay, changed approximately in parallel with changes in [Ca]int. Chemically induced hypoxia (CIH), induced by application of cyanide and 2-deoxy-glucose, caused a steady rise in [Ca]int. Calcium increased more rapidly on 'reoxygenation' by return to control solutions. The protein kinase C (PKC) activator PMA abolished both phases of calcium increase. The mitoKATP channel-selective blocker 5-hydroxydecanoate partially prevented the PMA-induced protection during CIH, but not during reoxygenation. In contrast, HMR 1098, a sarcKATP channel-selective blocker, abolished protection only during the reoxygenation. Adenosine (A1) receptor activation prevented or reduced increases in [Ca]int and improved cell viability via a PKC and mito/sarcKATP channel-dependent mechanism. PKC-dependent protection against cytoplasmic calcium increases was also observed in a human cell line (tsA201) transiently expressing sarcKATP channels. Protection was abolished only during the reoxygenation phase by the amino acid substitution (T180A) in the pore-forming Kir6.2 subunit, a mutation previously shown to prevent PKC-dependent modulation. Our data suggest that sarc and mitoKATP channel populations play distinct protective roles, triggered by PKC and/or adenosine, during chemically induced hypoxia/reoxygenation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • ATP-Binding Cassette Transporters
  • Adenosine / analogs & derivatives*
  • Adenosine / pharmacology
  • Adenosine Triphosphate / pharmacology
  • Animals
  • Benzamides / pharmacology
  • Calcium / metabolism
  • Cell Hypoxia / physiology
  • Cell Line
  • Cell Survival / drug effects
  • Cells, Cultured
  • Decanoic Acids / pharmacology
  • Dose-Response Relationship, Drug
  • Enzyme Activation / drug effects
  • Heart Ventricles / cytology
  • Heart Ventricles / drug effects
  • Humans
  • Hydroxy Acids / pharmacology
  • Ischemic Preconditioning, Myocardial
  • KATP Channels
  • Luminescent Proteins / genetics
  • Luminescent Proteins / metabolism
  • Membrane Potentials / drug effects
  • Mitochondria / metabolism*
  • Myocardium / metabolism
  • Oxygen / pharmacology
  • Potassium Channels / drug effects
  • Potassium Channels / genetics
  • Potassium Channels / physiology*
  • Potassium Channels, Inwardly Rectifying
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Rats
  • Recombinant Fusion Proteins / genetics
  • Recombinant Fusion Proteins / physiology
  • Sarcolemma / metabolism*
  • Time Factors
  • Ventricular Function
  • Xanthines / pharmacology

Substances

  • ATP-Binding Cassette Transporters
  • Benzamides
  • Decanoic Acids
  • Hydroxy Acids
  • KATP Channels
  • Luminescent Proteins
  • Potassium Channels
  • Potassium Channels, Inwardly Rectifying
  • Purinergic P1 Receptor Agonists
  • Purinergic P1 Receptor Antagonists
  • Recombinant Fusion Proteins
  • Xanthines
  • uK-ATP-1 potassium channel
  • 2-chloro-N(6)cyclopentyladenosine
  • 5-hydroxydecanoic acid
  • Adenosine Triphosphate
  • 1,3-dipropyl-8-cyclopentylxanthine
  • HMR 1098
  • Adenosine
  • Oxygen
  • Calcium